493 related articles for article (PubMed ID: 31788059)
1. Identification of key genes and evaluation of clinical outcomes in lung squamous cell carcinoma using integrated bioinformatics analysis.
Shi Y; Li Y; Yan C; Su H; Ying K
Oncol Lett; 2019 Dec; 18(6):5859-5870. PubMed ID: 31788059
[TBL] [Abstract][Full Text] [Related]
2. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
3. Identification of key biomarkers and potential molecular mechanisms in lung cancer by bioinformatics analysis.
Li Z; Sang M; Tian Z; Liu Z; Lv J; Zhang F; Shan B
Oncol Lett; 2019 Nov; 18(5):4429-4440. PubMed ID: 31611952
[TBL] [Abstract][Full Text] [Related]
4. Screening and identification of key biomarkers in lung squamous cell carcinoma by bioinformatics analysis.
Man J; Zhang X; Dong H; Li S; Yu X; Meng L; Gu X; Yan H; Cui J; Lai Y
Oncol Lett; 2019 Nov; 18(5):5185-5196. PubMed ID: 31612029
[TBL] [Abstract][Full Text] [Related]
5. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis.
Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X
Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076
[TBL] [Abstract][Full Text] [Related]
6. Screening Hub Genes as Prognostic Biomarkers of Hepatocellular Carcinoma by Bioinformatics Analysis.
Zhou Z; Li Y; Hao H; Wang Y; Zhou Z; Wang Z; Chu X
Cell Transplant; 2019 Dec; 28(1_suppl):76S-86S. PubMed ID: 31822116
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomics analysis of hub genes and their relationship with prognosis and signaling pathways in esophageal squamous cell carcinoma.
Chen FF; Zhang SR; Peng H; Chen YZ; Cui XB
Mol Med Rep; 2019 Oct; 20(4):3649-3660. PubMed ID: 31485619
[TBL] [Abstract][Full Text] [Related]
8. Integrated analysis reveals key genes with prognostic value in lung adenocarcinoma.
Song YJ; Tan J; Gao XH; Wang LX
Cancer Manag Res; 2018; 10():6097-6108. PubMed ID: 30538558
[TBL] [Abstract][Full Text] [Related]
9. Screening and identification of key biomarkers in adrenocortical carcinoma based on bioinformatics analysis.
Xing Z; Luo Z; Yang H; Huang Z; Liang X
Oncol Lett; 2019 Nov; 18(5):4667-4676. PubMed ID: 31611976
[TBL] [Abstract][Full Text] [Related]
10. Identification of key candidate tumor biomarkers in non-small-cell lung cancer by
Chen W; Zhu S; Zhang Y; Xiao J; Tian D
Oncol Lett; 2020 Jan; 19(1):1008-1016. PubMed ID: 31897214
[TBL] [Abstract][Full Text] [Related]
11. Identification of key genes associated with progression and prognosis for lung squamous cell carcinoma.
Ma X; Ren H; Peng R; Li Y; Ming L
PeerJ; 2020; 8():e9086. PubMed ID: 32411535
[TBL] [Abstract][Full Text] [Related]
12. Identification of genes and pathways leading to poor prognosis of non-small cell lung cancer using integrated bioinformatics analysis.
Cui S; Lou S; Feng J; Tang X; Xiao X; Huang R; Guo W; Zhou Y; Huang F
Transl Cancer Res; 2022 Apr; 11(4):710-724. PubMed ID: 35571642
[TBL] [Abstract][Full Text] [Related]
13. Hub genes and key pathways of non-small lung cancer identified using bioinformatics.
Tang Q; Zhang H; Kong M; Mao X; Cao X
Oncol Lett; 2018 Aug; 16(2):2344-2354. PubMed ID: 30008938
[TBL] [Abstract][Full Text] [Related]
14. Identification of Metastasis-Associated Biomarkers in Synovial Sarcoma Using Bioinformatics Analysis.
Song Y; Liu X; Wang F; Wang X; Cheng G; Peng C
Front Genet; 2020; 11():530892. PubMed ID: 33061942
[TBL] [Abstract][Full Text] [Related]
15. Screening key genes and signaling pathways in colorectal cancer by integrated bioinformatics analysis.
Yu C; Chen F; Jiang J; Zhang H; Zhou M
Mol Med Rep; 2019 Aug; 20(2):1259-1269. PubMed ID: 31173250
[TBL] [Abstract][Full Text] [Related]
16. Five genes may predict metastasis in non-small cell lung cancer using bioinformatics analysis.
Sun R; Meng X; Wang W; Liu B; Lv X; Yuan J; Zeng L; Chen Y; Yuan B; Yang S
Oncol Lett; 2019 Aug; 18(2):1723-1732. PubMed ID: 31423239
[TBL] [Abstract][Full Text] [Related]
17. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer.
Liu X; Liu X; Li J; Ren F
Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030
[TBL] [Abstract][Full Text] [Related]
18. Integrated bioinformatics analysis reveals key candidate genes and pathways in breast cancer.
Wang Y; Zhang Y; Huang Q; Li C
Mol Med Rep; 2018 Jun; 17(6):8091-8100. PubMed ID: 29693125
[TBL] [Abstract][Full Text] [Related]
19. Identification of Key Biomarkers and Potential Molecular Mechanisms in Renal Cell Carcinoma by Bioinformatics Analysis.
Li F; Guo P; Dong K; Guo P; Wang H; Lv X
J Comput Biol; 2019 Nov; 26(11):1278-1295. PubMed ID: 31233342
[No Abstract] [Full Text] [Related]
20. Common and distinct features of potentially predictive biomarkers in small cell lung carcinoma and large cell neuroendocrine carcinoma of the lung by systematic and integrated analysis.
Dong S; Liang J; Zhai W; Yu Z
Mol Genet Genomic Med; 2020 Mar; 8(3):e1126. PubMed ID: 31981472
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]